Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview
Vaccines · 31.01.2025 · 13 (2) · 148
DOI: 10.3390/vaccines13020148 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 31.01.2025. Verfasst von Alex C Boomgarden und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
The development of an effective HIV-1 vaccine remains a formidable challenge in biomedical research. Despite significant advancements in our understanding of HIV biology and pathogenesis, progress has been impeded by factors such as the virus's genetic diversity, high mutation rates, and its ability to establish latent reservoirs. Recent innovative approaches, including mosaic vaccines and mRNA technology to induce broadly neutralizing antibodies, have shown promise. However, the efficacy of these vaccines has been modest, with the best results achieving approximately 30% effectiveness. Ongoing research emphasizes the necessity of a multifaceted strategy to overcome these obstacles and achieve a breakthrough in HIV-1 vaccine development. This review summarizes current approaches utilized to further understand HIV-1 biology and to create a global vaccine. We discuss the impact of these approaches on vaccine development for other diseases, including COVID-19, influenza, and Zika virus. Additionally, we highlight the specific limitations faced with each approach and present the methods researchers employ to overcome these challenges. These innovative techniques, which have demonstrated preclinical and clinical success, have advanced the field closer to the ultimate goal of developing a global HIV-1 vaccine. Leveraging these advancements will enable significant strides in combating HIV-1 and other infectious diseases, ultimately improving global health outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
ORCID-Profile: Alex C Boomgarden, Chitra Upadhyay
Förderung
- NIAID NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Boomgarden, A. C., & Upadhyay, C. (2025). Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview. Vaccines, 13(2), 148. https://doi.org/10.3390/vaccines13020148
Vancouver
Boomgarden AC, Upadhyay C. Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview. Vaccines. 2025;13(2):148. doi:10.3390/vaccines13020148
BibTeX
@article{Boomgarden2025,
author = {Boomgarden, Alex C and Upadhyay, Chitra},
title = {Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview},
journal = {Vaccines},
year = {2025},
volume = {13},
number = {2},
pages = {148},
doi = {10.3390/vaccines13020148}
}
EUVIMED